Lactic Acidosis: Pathophysiology, Diagnosis, and Nursing Management

Sawsan Hussain Ali Alsaleh (1), Maryam Hussin Habib Alabood (1), Laila Eissa Abdullah Alatwan (1), Latifah Farhan Ahmed AlQasim (1), Eman Ali Khalifah Al Farhan (2), Sukinah Saleh Jasem Aljubran (1), Aisha Adel Abdulaziz Alsaqer (2), Hajer Saleh Yousef Alowaidh (2), Amal Rashed Fahed Alkhammash (3), Hind Nahar Hmad Alhagriaf , Amerah Saleh Ibrahim  Aljamaan (2), Amenah Nasser Abdullah AlnefIly (4)
(1) Maternity and children hospital Alahsa, Saudi Arabia,
(2) King Faisal General Hospital, Ministry of Health, Saudi Arabia,
(3) maternity and child hospital in Alahsa, Saudi Arabia,
(4) Maternity and Children's Hospital in Al-Ahs, Saudi Arabia

Abstract

Background: Lactic acidosis is a critical metabolic condition characterized by the systemic accumulation of lactate, resulting from an imbalance between its production and clearance. It is commonly classified into Type A, caused by tissue hypoperfusion and hypoxia (e.g., shock), and Type B, associated with underlying diseases, toxins, or mitochondrial dysfunction. It is a frequent finding in critically ill patients and is strongly linked to high mortality rates.


Aim: This article aims to comprehensively review the pathophysiology, diagnosis, and management of lactic acidosis, with a specific focus on the integral role of nursing in early recognition, monitoring, and coordinating interdisciplinary care to improve patient outcomes.


Methods: The article synthesizes current medical knowledge on lactic acidosis, detailing its physiological mechanisms, risk factors, and diagnostic criteria. It outlines systematic approaches for assessment, evaluation (including arterial blood gas and anion gap analysis), and evidence-based medical and nursing interventions.


Results: Effective management hinges on rapid identification and treatment of the underlying cause, such as infection source control in sepsis. Medical management involves goal-directed fluid resuscitation, vasopressor support, and optimizing oxygen delivery. Serial lactate monitoring and clinical assessment of perfusion are crucial for evaluating treatment efficacy. Nursing management is pivotal in executing these interventions, providing continuous monitoring, and ensuring coordinated, patient-centered care.


Conclusion: Lactic acidosis is a life-threatening condition requiring a prompt, systematic, and interdisciplinary approach. Successful outcomes depend on correcting the underlying cause, restoring tissue perfusion, and meticulous supportive care, with nurses playing a central role in monitoring, intervention, and care coordination.

Full text article

Generated from XML file

References

Kamel KS, Oh MS, Halperin ML. L-lactic acidosis: pathophysiology, classification, and causes; emphasis on biochemical and metabolic basis. Kidney Int. 2020 Jan;97(1):75-88.

Zanza C, Facelli V, Romenskaya T, Bottinelli M, Caputo G, Piccioni A, Franceschi F, Saviano A, Ojetti V, Savioli G, Longhitano Y. Lactic Acidosis Related to Pharmacotherapy and Human Diseases. Pharmaceuticals (Basel). 2022 Nov 30;15(12)

Gillies RJ, Pilot C, Marunaka Y, Fais S. Targeting acidity in cancer and diabetes. Biochim Biophys Acta Rev Cancer. 2019 Apr;1871(2):273-280.

Radelfahr F, Klopstock T. [Mitochondrial diseases]. Nervenarzt. 2019 Feb;90(2):121-130.

Kraut JA, Madias NE. Lactic acidosis. N Engl J Med. 2014 Dec 11;371(24):2309-19.

Weisberg LS. Lactic Acidosis in a Patient with Type 2 Diabetes Mellitus. Clin J Am Soc Nephrol. 2015 Aug 07;10(8):1476-83.

Claudino WM, Dias A, Tse W, Sharma VR. Type B lactic acidosis: a rare but life threatening hematologic emergency. A case illustration and brief review. Am J Blood Res. 2015;5(1):25-9.

Agedal KJ, Steidl KE, Burgess JL. An Overview of Type B Lactic Acidosis Due to Thiamine (B1) Deficiency. J Pediatr Pharmacol Ther. 2023;28(5):397-408.

Bianchetti DGAM, Amelio GS, Lava SAG, Bianchetti MG, Simonetti GD, Agostoni C, Fossali EF, Milani GP. D-lactic acidosis in humans: systematic literature review. Pediatr Nephrol. 2018 Apr;33(4):673-681.

Corremans R, Vervaet BA, D'Haese PC, Neven E, Verhulst A. Metformin: A Candidate Drug for Renal Diseases. Int J Mol Sci. 2018 Dec 21;20(1)

Donnan K, Segar L. SGLT2 inhibitors and metformin: Dual antihyperglycemic therapy and the risk of metabolic acidosis in type 2 diabetes. Eur J Pharmacol. 2019 Mar 05;846:23-29.

Jung B, Rimmele T, Le Goff C, Chanques G, Corne P, Jonquet O, Muller L, Lefrant JY, Guervilly C, Papazian L, Allaouchiche B, Jaber S., AzuRea Group. Severe metabolic or mixed acidemia on intensive care unit admission: incidence, prognosis and administration of buffer therapy. A prospective, multiple-center study. Crit Care. 2011;15(5):R238.

Authors

Sawsan Hussain Ali Alsaleh
Sahalsaleh@moh.gov.sa (Primary Contact)
Maryam Hussin Habib Alabood
Laila Eissa Abdullah Alatwan
Latifah Farhan Ahmed AlQasim
Eman Ali Khalifah Al Farhan
Sukinah Saleh Jasem Aljubran
Aisha Adel Abdulaziz Alsaqer
Hajer Saleh Yousef Alowaidh
Amal Rashed Fahed Alkhammash
Hind Nahar Hmad Alhagriaf
Amerah Saleh Ibrahim  Aljamaan
Amenah Nasser Abdullah AlnefIly
Alsaleh, S. H. A., Maryam Hussin Habib Alabood, Laila Eissa Abdullah Alatwan, Latifah Farhan Ahmed AlQasim, Eman Ali Khalifah Al Farhan, Sukinah Saleh Jasem Aljubran, … Amenah Nasser Abdullah AlnefIly. (2025). Lactic Acidosis: Pathophysiology, Diagnosis, and Nursing Management. Saudi Journal of Medicine and Public Health, 2(2), 823–831. https://doi.org/10.64483/202522210

Article Details

Similar Articles

1 2 3 4 5 > >> 

You may also start an advanced similarity search for this article.